Skip to main content
Caplight Logo









Stradefy Biosciences

Stradefy Biosciences

Private
New Haven, ConnecticutHealthcare & Life Scienceshttps://stradefybio.com/

Last Round

VC Round

Dec 1, 2021

Company Overview

Stradefy Biosciences is a biotechnology company that develops next-generation bioadhesive drug carriers for targeted oncology and immunology applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Advanced Materials, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

nanoparticle drug deliverybioadhesive drug carriersBDCdrug delivery platformoncology therapeuticsimmunology therapeuticsdrug discoverypreclinical developmentpolymer nanoparticlestargeted drug deliverybiotech startuptherapeutic payloadinvestigational new drugINDdrug delivery tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Stradefy Biosciences Comparables

Compare Stradefy Biosciences with similar companies based on industry and business-model similarity.

Stradefy Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BreezeBio
83%
Xanadu Bio
82%
Nouveau BioSciences
82%

Stradefy Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundDec 1, 2021

Stradefy Biosciences Investors

Notable investors and investment history

Stradefy Biosciences investors
InvestorRounds
Elm Street VenturesVC Round
Yale UniversityVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2021

    Led by Elm Street Ventures with participation from Yale University.

Stradefy Biosciences Filings

Explore SEC and related filing metadata, where available.

Stradefy Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Stradefy Biosciences's valuation, stock price, and market status.

Is Stradefy Biosciences a public or private company?

Stradefy Biosciences is a private company.

What is the current stock price of Stradefy Biosciences?

Stradefy Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Stradefy Biosciences worth (valuation)?

Valuation information for Stradefy Biosciences is not publicly available.

Can I buy Stradefy Biosciences stock?

Stradefy Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Stradefy Biosciences's last funding round?

Stradefy Biosciences's most recent funding round was VC Round on December 1, 2021.

Who are the main investors in Stradefy Biosciences?

Key investors in Stradefy Biosciences include Elm Street Ventures.

Will Stradefy Biosciences IPO soon?

No public IPO plans have been announced for Stradefy Biosciences.

How can I track Stradefy Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Stradefy Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew Haven, Connecticut
Year Founded2019
Last FundingDec 1, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?